Transcriptomics

Dataset Information

0

Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer.


ABSTRACT: Patients with prostate cancer (PC) generally do not respond favorably to immune checkpoint inhibitors, which may be due to a low abundance of tumor-infiltrating lymphocytes even when mutational load is high. Here, we identified a patient who presented with high-grade primary prostate cancer with two adjacent tumor nodules. While both nodules were mismatch repair- deficient (MMRd), exhibited pathogenic MSH2 and MSH6 alterations, had a high tumor mutational burden (TMB), and demonstrated high microsatellite instability (MSI), they had markedly distinct immune phenotypes. The first displayed a dense infiltrate of lymphocytes (“hot nodule”), while the second displayed significantly fewer infiltrating lymphocytes (“cold nodule”). Whole-exome DNA analysis found that both nodules shared many identical mutations, indicating that they were derived from a single clone. However, the cold nodule appeared to be sub-clonal relative to the hot nodule, suggesting divergent evolution of the cold nodule from the hot nodule. Whole-transcriptome RNA analysis found that the cold nodule demonstrated lower expression of genes related to antigen presentation (HLA) and, paradoxically, classical tumor immune tolerance markers such as PD-L1 (CD274) and CTLA-4. Immune cell deconvolution suggested that the hot nodule was enriched not only in CD8+ and CD4+ T lymphocytes, but also in M1 macrophages, activated NK cells, and gamma delta T cells compared to the cold nodule. This case highlights that MMRd/TMB-high PC can evolve to minimize an anti-tumor immune response, and nominates downregulation of antigen presentation machinery (HLA loss) as a potential mechanism of adaptive immune evasion in PC.

ORGANISM(S): Homo sapiens

PROVIDER: GSE246684 | GEO | 2023/10/31

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-04-28 | GSE146100 | GEO
2021-08-23 | PXD022949 | Pride
2023-12-01 | GSE155724 | GEO
2023-12-01 | GSE155723 | GEO
2023-12-01 | GSE155722 | GEO
2022-10-07 | GSE212217 | GEO
2024-02-10 | GSE255107 | GEO
2021-11-09 | GSE178119 | GEO
2023-12-01 | GSE189925 | GEO
2010-06-05 | E-GEOD-780 | biostudies-arrayexpress